Correction: Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma

作者：Wuyang Yun, Yuyu Li, Yanlei Ge, Xiaoyun Zhang, Huifeng Liu, Wen Chen, Xiao Li · 发表于：Frontiers in Cell and Developmental Biology · 年份：2025 · DOI：10.3389/fcell.2025.1728870 · 被引用次数：1 · 研究领域：Lung Cancer Research Studies、Lung Cancer Treatments and Mutations、Cancer Cells and Metastasis

A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval.• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in figure 1C as published. In Figure 1c, the culture time for the adherent model was incorrectly stated as "2-3 weeks." The correct cultivation time for the adhesive model should be 2-3 days.The corrected figure appears below. The original version of this article has been updated.